Ownership history in MATHER GROUP, LLC. · 12 quarters on record
This page tracks every 13F SEC filing in which MATHER GROUP, LLC. reported a position in WEST PHARMACEUTICAL SVSC INC (WST). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 686 | -198 | -22.4% | 0.00% | $180K | $261.88 |
| 2025 Q1 | REDUCED | 884 | -225 | -20.3% | 0.00% | $198K | $223.09 |
| 2024 Q4 | REDUCED | 1,109 | -357 | -24.4% | 0.00% | $363K | $326.20 |
| 2024 Q3 | ADDED | 1,466 | +143 | +10.8% | 0.01% | $440K | $298.72 |
| 2024 Q2 | ADDED | 1,323 | +142 | +12.0% | 0.01% | $524K | $327.59 |
| 2024 Q1 | UNCHANGED | 1,181 | — | 0% | 0.01% | $416K | $393.34 |
| 2023 Q4 | REDUCED | 1,181 | -54 | -4.4% | 0.01% | $416K | $349.82 |
| 2023 Q3 | ADDED | 1,235 | +46 | +3.9% | 0.01% | $463K | $372.54 |
| 2023 Q2 | ADDED | 1,189 | +297 | +33.3% | 0.01% | $455K | $379.56 |
| 2023 Q1 | REDUCED | 892 | -119 | -11.8% | 0.01% | $309K | $343.66 |
As of 2025 Q4 — sorted by position size